Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

VOXELPLUS PACS

K-Number: K022692 · 2002-10-11

Decision Date2002-10-11
Product CodeLLZ
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

VOXELPLUS PACS is the device name listed in this FDA 510(k) record. The listed applicant is Mevisys Co., Ltd.. It received FDA 510(k) clearance on 2002-10-11 under 510(k) number K022692. The device is classified under product code LLZ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the VOXELPLUS PACS?

VOXELPLUS PACS is a medical device that received FDA 510(k) clearance on 2002-10-11. The listed applicant is Mevisys Co., Ltd.. The 510(k) number is K022692.

When did VOXELPLUS PACS receive FDA 510(k) clearance?

VOXELPLUS PACS received FDA 510(k) clearance on 2002-10-11, under 510(k) number K022692.

Who is the listed applicant for VOXELPLUS PACS?

The FDA 510(k) record lists Mevisys Co., Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for VOXELPLUS PACS?

The FDA product code for VOXELPLUS PACS is LLZ.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Other records listing Mevisys Co., Ltd. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: LLZ)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑